VCF1

VCF1 (FAM104A) is a nuclear cofactor of the AAA-ATPase p97/VCP that binds the p97 N-domain with unusually high affinity via a conserved alpha-helical motif, promoting p97 nuclear import; loss of VCF1 reduces nuclear p97 levels, impairs cell growth, and confers hypersensitivity to p97 inhibition (PMID:37713320). VCF1 forms a joint complex with p97 and UFD1-NPL4, where it indirectly stimulates UFD1-NPL4 interactions with ubiquitin conjugates—without possessing intrinsic ubiquitin-binding activity itself—thereby facilitating p97-UFD1-NPL4-dependent proteasomal degradation of ubiquitylated substrates (PMID:38503733).

1. 2023 High

   Establishing VCF1 as a direct p97 cofactor resolved what had been an uncharacterized gene (FAM104A) into a nuclear-localized p97 adaptor that promotes p97 nuclear import and is functionally required for normal growth and resistance to p97 inhibition.

   Evidence Direct binding assays, reciprocal co-immunoprecipitation of endogenous complexes, subcellular fractionation/imaging, and loss-of-function growth/drug-sensitivity phenotyping in human cells

   PMID:37713320

   Open questions at the time

   • The structural basis of the VCF1–p97 interaction was not resolved at atomic resolution
   • Whether VCF1 affects p97 substrate processing beyond facilitating nuclear import was unknown
   • Relative affinity of VCF1 for p97 compared with other cofactors was not determined
2. 2024 High

   Structure-function dissection revealed that VCF1 binds p97 with affinity exceeding other known cofactors and indirectly stimulates UFD1-NPL4 engagement with ubiquitin conjugates, establishing VCF1 as an allosteric enhancer of p97-dependent substrate degradation rather than a direct ubiquitin receptor.

   Evidence NMR-based structural characterization, quantitative biophysical affinity measurements, mutagenesis of the alpha-helical binding motif, and in-cell ubiquitylated substrate degradation assays

   PMID:38503733

   Open questions at the time

   • The atomic-resolution structure of the full VCF1–p97–UFD1-NPL4 complex has not been determined
   • Specific endogenous nuclear substrates whose turnover depends on VCF1 remain unidentified
   • The mechanism by which VCF1 allosterically stimulates UFD1-NPL4 ubiquitin-conjugate recognition is unclear

• It remains unknown which specific nuclear pathways (e.g., chromatin-associated degradation, DNA repair) depend on VCF1-mediated p97 recruitment, and whether VCF1 and its paralog VCF2 have redundant or distinct substrate-specific roles in vivo.
• No in vivo model (animal knockout) has been reported
• Functional redundancy between VCF1 and VCF2 has not been systematically dissected
• Disease relevance of VCF1 loss-of-function remains unexplored